{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:40:03Z","timestamp":1786545603023,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T00:00:00Z","timestamp":1551052800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ACG Case Rep J","ACG Case Reports Journal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Voriconazole-induced hepatotoxicity is a relatively rare but serious clinicopathologic entity. This drug is frequently used for invasive aspergillosis and other fungal infections. We report a patient with alcoholic cirrhosis who developed hepatic encephalopathy due to voriconazole administered for invasive pulmonary aspergillosis and subsequently showed marked improvement in mental status with dose adjustment of the drug. The patient eventually underwent an uneventful liver transplant. Histopathologic examination of the diseased liver specimen revealed numerous rhomboid-shaped crystals, deemed secondary to liver injury after voriconazole-induced hepatotoxicity. Additionally, this article briefly reviews the available data on voriconazole-induced hepatotoxicity with special emphasis on plasma drug concentration monitoring.<\/jats:p>","DOI":"10.14309\/crj.0000000000000010","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T16:27:56Z","timestamp":1551803276000},"page":"e00010","source":"Crossref","is-referenced-by-count":3,"title":["Voriconazole-Induced Hepatotoxicity Presenting With Severe Hepatic Encephalopathy After Liver Transplantation"],"prefix":"10.14309","volume":"6","author":[{"given":"Syed Haris","family":"Tasleem","sequence":"first","affiliation":[{"name":"Division of Multi-Organ Transplantation, William Beaumont Hospital, Royal Oak, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell S.","family":"Cappell","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, William Beaumont Hospital, Royal Oak, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,2,25]]},"reference":[{"issue":"4","key":"R1-20230717","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ajg.2017.471","article-title":"Prediction of fungal infection development and their impact on survival using the NACSELD Cohort","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"R2-20230717","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"12","key":"R3-20230717","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/infdis\/jiu017","article-title":"Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotype","volume":"209","author":"Zonios","year":"2014","journal-title":"J Infect Dis"},{"issue":"11","key":"R4-20230717","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/ctr.12834","article-title":"Adverse effects of voriconazole: Over a decade of use","volume":"30","author":"Levine","year":"2016","journal-title":"Clin Transpl"},{"issue":"1","key":"R5-20230717","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jinf.2012.09.011","article-title":"Voriconazole hepatotoxicity in severe liver dysfunction","volume":"66","author":"Solis-Munoz","year":"2013","journal-title":"J Infect"},{"issue":"1","key":"R6-20230717","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/14740330903485637","article-title":"Voriconazole therapeutic drug monitoring: Focus on safety","volume":"9","author":"Pasqualotto","year":"2010","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"R7-20230717","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jac\/dkw045","article-title":"Trough concentration of voriconazole and its relationship with efficacy and safety: A systematic review and meta-analysis","volume":"71","author":"Jin","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"R8-20230717","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1155\/2014\/214813","article-title":"Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy","volume":"25","author":"Saini","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"R9-20230717","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1471-2334-13-105","article-title":"Voriconazole therapeutic drug monitoring: Retrospective cohort study of the relationship to clinical outcomes and adverse events","volume":"13","author":"Chu","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"5","key":"R10-20230717","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/00498254.2011.631224","article-title":"Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes","volume":"42","author":"Zhang","year":"2012","journal-title":"Xenobiotica"},{"issue":"5","key":"R11-20230717","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1128\/AAC.01316-08","article-title":"Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation","volume":"53","author":"Trifilio","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"R12-20230717","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1086\/374248","article-title":"Safety of voriconazole and dose individualization","volume":"36","author":"Lutsar","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"42","key":"R13-20230717","doi-asserted-by":"crossref","first-page":"e8039","DOI":"10.1097\/MD.0000000000008039","article-title":"Significance of monitoring plasma concentration of voriconazole in a patient with liver failure: A case report","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine (Baltimore)"}],"container-title":["ACG Case Reports Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/02075970-201903000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:43:51Z","timestamp":1786542231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02075970-201903000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,25]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.14309\/crj.0000000000000010","relation":{},"ISSN":["2326-3253"],"issn-type":[{"value":"2326-3253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,25]]}}}